BM Equity Report - Concord Biotech IPO & Indian consumer slowdown

Concord Biotec is an IPO that one can invest into. The sales growth is strong while profits are flat. This is normal with pharma companies. Meanwhile, the Indian middle class continues to spend less - burdened by inflation while the upper class seems unaffected. The Fed made conflicting views on inflation and we discuss all this and also Elon Musk’s offer for people on Twitter. ——— Invest in our Smallcase : Basant Maheshwari Smallcase: https://basantmaheshwari.smallcase.com ——— Buy my book: The Thoughtful Investor only from our website https://www.thethoughtfulinvestor.in ——— For Personal Consultation on business or finance: Please send a WhatsApp message at +91 85918 66511 or email to support@theequitydesk.com -—— Covered This Video 0:00 Intro 0:18 CONCORD BIOTEC Business Model 1:29 Problem Of CONCORD BIOTEC 3:28 My Opinion Of CONCORD BIOTEC 4:25 Consumer Sector 6:00 FED Governor Commentary 6:34 US Car Market 7:22 BILL ACKMAN 8:43 INDIAN Market 8:59 ELON MUSK 10:55 Overall Market 11:13 JP MORGAN STATEMENT #concordbiotech #billackman #mutualfunds #sip #interestratehike #dowjones #cement #bondmarket #fed #tradingeducation #fedstocks #elonmusk #indiansharemarket #stockmarket #internationalsharemarket #ipo #concordbitech #investment #sharemarkettoday #stockmarketupdate #stockmarketanalysis ——— Social Media Handles: Twitter: https://twitter.com/BMTheEquityDesk Facebook: https://www.facebook.com/bmtheequitydesk Instagram: https://www.instagram.com/bmtheequitydesk

Category